Revvity, Inc.
- RVTY
- NYSE
- Medical - Diagnostics & Research
- Diagnostics & Life Science Tools
- Pharmaceutical R&D Solutions
$150.94
Today −1.11%Quote Oct 19, 2026, 08:00 PM UTC
+5.22%over the last month
Max drawdown −4.1%From 1-month high −4.1%3 months +36.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Revvity
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide.
Where the money comes from
Q2 2026 revenue $729.7M
- Diagnostics$371.0M50.8%
- Life Sciences$358.7M49.2%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Employees
11,000
Founded
1937
Dividend date
Nov 13, 2026
Market value
$16.84B
Quote Oct 19
Floor
$148.31
1.7% below price
Resistance
$151.02
0.1% above price
Price vs analyst targets
29 analysts
Lowest target
$100.00Highest target
$165.00
$100.00Highest target
$165.00
- Price $150.94
- Average target $132.13
- Analysts' target range
Analysts' average target sits about 12% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RVTYPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free